Lebanon, NJ, United States of America

Russell R Hanner

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Roussel Pharmaceuticals. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell R Hanner. Retrieved from https://idiyas.com/inventor/russell-r-hanner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Russell R. Hanner: Pioneering Medicines for Future Health

Introduction:

Russell R. Hanner, a notable inventor based in Lebanon, NJ, has made significant contributions to the field of pharmaceuticals. With one patent to his name, Hanner is recognized for his innovative work in developing compounds aimed at improving health outcomes.

Latest Patents:

Hanner's patent focuses on the creation of 1-alkyl-, 1-alkenyl-, and 1-alkylnlaryl-2-amino-1,3-propanediols. This invention includes novel processes for preparing these compounds and highlights their potential applications in reducing inflammation, inhibiting cell proliferation, alleviating memory dysfunction, and combating bacterial and fungal growth.

Career Highlights:

Russell R. Hanner’s career reached a significant milestone while working at Hoechst Roussel Pharmaceuticals. His dedication to pharmaceutical innovation has been a pivotal part of his professional journey, helping to pave the way for new therapeutic approaches.

Collaborations:

Throughout his career, Hanner has collaborated closely with esteemed colleagues such as John J. Tegeler and Barbara S. Rauckman. These partnerships have been instrumental in driving forward his research and the development of his patentable innovations.

Conclusion:

Russell R. Hanner's work exemplifies the essence of innovation in the pharmaceutical industry. His contributions through patenting novel compounds demonstrate the impact that dedicated inventors can have on advancing healthcare solutions. As he continues his journey, Hanner remains a key figure in the quest for improved medicinal therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…